Happy Friday! This exclusive edition of The Funding Letter comes to you from our headquarters in New York City. Have a great weekend!
Hit the Gong 🎉
Source: @sales_humor
Need ONE newsletter to stay on top of everything?
Prompts daily will make you more productive at work and help you look smarter in front of your friends (seriously!)
It’s also FREE to sign up!
Daily Deals 💸
🌎 Americas
Cerevance has developed novel therapeutics that advance new medicines for central nervous system diseases, enabling healthcare providers to detect and tackle the early onset of various neurological diseases. View on: LinkedIn.com | Sales Navigator.
New Funding Raised: $47M, Series B
Round Investors: Agent Capital (lead), Bioluminescence Ventures (lead), Double Point Ventures (lead), MQB Partners
🚀Growth Focus: Advance Cerevance’s first-in-class pre-clinical and clinical programs, including initiation of the Phase 3 clinical trial for CVN424.
Press: GlobeNewswire, BioSpace
HQ: Boston, MA
Industry: Biotechnology Research
Employee Count: 58
AccessHope provides cancer breakthrough services delivering a revolutionary employee health benefit that connects cancer patients and their families with expertise from a National Cancer Institute-designated comprehensive cancer center, helping to develop precise plans for treatment. View on: LinkedIn.com | Sales Navigator.
New Funding Raised: $33M, Series B
Round Investors: City of Hope
🚀Growth Focus: Accelerate innovation and expand into new markets and regions, that extend access to the best cancer treatment expertise regardless of who you are and where you live.
Press: PR Newswire, HIT Consultant
HQ: Duarte, CA
Industry: Hospitals and Health Care
Employee Count: 125